Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Entrada Therapeutics (TRDA) EPS (Basic): 2022-2024

Historic EPS (Basic) for Entrada Therapeutics (TRDA) over the last 3 years, with Dec 2024 value amounting to $1.76.

  • Entrada Therapeutics' EPS (Basic) fell 202.86% to -$1.06 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.55, marking a year-over-year decrease of 252.69%. This contributed to the annual value of $1.76 for FY2024, which is 980.00% up from last year.
  • Per Entrada Therapeutics' latest filing, its EPS (Basic) stood at $1.76 for FY2024, which was up 980.00% from -$0.20 recorded in FY2023.
  • Entrada Therapeutics' 5-year EPS (Basic) high stood at $1.76 for FY2024, and its period low was -$3.02 during FY2022.
  • Over the past 3 years, Entrada Therapeutics' median EPS (Basic) value was -$0.20 (recorded in 2023), while the average stood at -$0.49.
  • Data for Entrada Therapeutics' EPS (Basic) shows a peak YoY surged of 980.00% (in 2024) over the last 5 years.
  • Entrada Therapeutics' EPS (Basic) (Yearly) stood at -$3.02 in 2022, then surged by 93.38% to -$0.20 in 2023, then skyrocketed by 980.00% to $1.76 in 2024.